ğŸ“Š HEALTH TOPIC OF THE WEEK: PHARMACOGENOMICS PANEL

The right drug at the right dose. Pharmacogenomics testing predicts how YOU will respond to medicationsâ€”avoiding adverse reactions and treatment failures.

Key Genes:

ğŸ§¬ CYP2D6: Codeine, antidepressants, tamoxifen
ğŸ§¬ CYP2C19: Plavix, PPIs, antidepressants
ğŸ§¬ CYP2C9: Warfarin, NSAIDs, sulfonylureas
ğŸ§¬ CYP3A4: Statins, calcium blockers, many drugs
ğŸ§¬ SLCO1B1: Statin myopathy risk
ğŸ§¬ VKORC1: Warfarin sensitivity
ğŸ§¬ HLA-B*5701: Abacavir hypersensitivity
ğŸ§¬ DPYD: 5-FU toxicity risk

Why It Matters:

7% of FDA-approved drugs have PGx labeling.

Poor metabolizers may need lower doses.
Ultra-rapid metabolizers may need higher doses or different drugs.

One test, lifetime guidance.

Testing Options:

ğŸ”¬ Panels: GeneSight, Genomind, RightMed, OneOme
ğŸ”¬ Cost: $200-400 (often covered by insurance)

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#HealthTopic #Pharmacogenomics #PersonalizedMedicine #DrugResponse #Bioscope
